Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Submitted by
admin
on September 21, 2017 - 10:18pm
Source:
Fierce Pharma
News Tags:
Pfizer
Ibrance
breast cancer
Headline:
Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Do Not Allow Advertisers to Use My Personal information
